371 related articles for article (PubMed ID: 2487543)
21. Antiplatelet therapy in the prevention of stroke.
Easton JD
Drugs; 1991; 42 Suppl 5():39-50. PubMed ID: 1726215
[TBL] [Abstract][Full Text] [Related]
22. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
Toth PP
Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
[TBL] [Abstract][Full Text] [Related]
23. [Low-dose aspirin in the long-term treatment of the patient with ischemic heart disease].
Magnani B; Semprini F
Cardiologia; 1994 Dec; 39(12 Suppl 1):15-21. PubMed ID: 7634259
[TBL] [Abstract][Full Text] [Related]
24. Are agents affecting platelet functions clinically useful?
Verstraete M
Am J Med; 1976 Dec; 61(6):897-914. PubMed ID: 795299
[TBL] [Abstract][Full Text] [Related]
25. Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: study design of the sibrafiban versus aspirin to yield maximum protection from ischemic heart events post-acute coronary syndromes (SYMPHONY) trial. Symphony Steering Committee.
Newby LK
Am Heart J; 1999 Aug; 138(2 Pt 1):210-8. PubMed ID: 10426831
[TBL] [Abstract][Full Text] [Related]
26. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
Arjomand H; Cohen M; Ezekowitz MD
J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
[TBL] [Abstract][Full Text] [Related]
27. Platelet inhibitor therapy. Agents and clinical implications.
Webster MW; Chesebro JH; Fuster V
Hematol Oncol Clin North Am; 1990 Feb; 4(1):265-89. PubMed ID: 2179212
[TBL] [Abstract][Full Text] [Related]
28. Advances in antithrombotic therapy of acute myocardial infarction.
Gensini GF; Comeglio M; Falai M
Am Heart J; 1999 Aug; 138(2 Pt 2):S171-6. PubMed ID: 10426878
[TBL] [Abstract][Full Text] [Related]
29. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
Prescrire Int; 2000 Jun; 9(47):83-5. PubMed ID: 11010749
[TBL] [Abstract][Full Text] [Related]
30. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Turpie AG
Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
[TBL] [Abstract][Full Text] [Related]
31. Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position.
McNicol GP
Lancet; 1980 Oct; 2(8197):736-8. PubMed ID: 6106840
[No Abstract] [Full Text] [Related]
32. [Antithrombotic treatment as primary and secondary prevention of stroke].
Chukanova EI; Chukanova AS; Nadareyshvili GG; Gulieva MS
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):85-88. PubMed ID: 28635860
[TBL] [Abstract][Full Text] [Related]
33. Antithrombotic therapy in acute coronary syndromes.
Buerke M; Rupprecht HJ
EXS; 2000; 89():193-209. PubMed ID: 10997290
[TBL] [Abstract][Full Text] [Related]
34. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
[TBL] [Abstract][Full Text] [Related]
35. Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
Mehta SR; Yusuf S
J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):79S-88S. PubMed ID: 12644345
[TBL] [Abstract][Full Text] [Related]
36. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2006 Apr; (2):CD001820. PubMed ID: 16625549
[TBL] [Abstract][Full Text] [Related]
37. Clopidogrel in acute coronary heart disease.
Din JN; Fox KA
Am Heart Hosp J; 2005; 3(4):234-42. PubMed ID: 16330915
[TBL] [Abstract][Full Text] [Related]
38. Platelet inhibitor agents in cardiovascular disease: an update.
Stein B; Fuster V; Israel DH; Cohen M; Badimon L; Badimon JJ; Chesebro JH
J Am Coll Cardiol; 1989 Oct; 14(4):813-36. PubMed ID: 2677086
[TBL] [Abstract][Full Text] [Related]
39. Risk factors, interventions and therapeutic agents in the prevention of atherosclerosis-related ischaemic diseases.
Verstraete M
Drugs; 1991; 42 Suppl 5():22-38. PubMed ID: 1726214
[TBL] [Abstract][Full Text] [Related]
40. [Acute coronary syndromes: an update. I. Pathogenesis and drug therapy].
Auer J; Berent R; Maurer E; Mayr H; Weber T; Eber B
Herz; 2001 Mar; 26(2):99-110. PubMed ID: 11349620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
